AbbVie’s Allergan Aesthetics launches Botox for MMP in China

Allergan Aesthetics, an AbbVie company, announced that Botox Cosmetic is now available for the treatment of masseter muscle prominence in China. The masseter is one of the muscles in the lower face involved in chewing, and prominence of the masseter muscle can result in a wide and square lower face shape. Botox Cosmetic was recently approved for the temporary improvement in the appearance of marked to very marked MMP in adults by the China National Medical Product Administration. Botox Cosmetic is the first neurotoxin approved in China for MMP and offers the established dosing, robust clinical evidence and physician training that comes with on-label treatment.